Gregory L. Weaver, Chief Financial Officer at PONIARD PHARMACEUTICALS, INC. (PARD), bought 2,000 shares at $2.05 ($4K) on 2009-04-06, disclosed to the SEC on 2009-04-06.
Open-market purchase of $4k PARD by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 200 | $410 | 9.9% |
| 2 | $2.07 | 1,575 | $3K | 78.7% |
| 3 | $2.10 | 225 | $473 | 11.4% |
| Total | $2.07 avg | 2,000 | $4K | 100% |
| Filing → |
| ALT | BUY | 2025-03-14 | $52K | — | Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |